The STIMO-2 study aims to investigate TESS-supported rehabilitation training in sub-acute spinal cord injury (\< 6 months post-injury). The primary endpoint of this study is to assess the safety and feasibility of TESS. The preliminary effectiveness of the therapy is the secondary study endpoint. The mobility recovery status of patients, who undergo TESS-supported rehabilitation, will be assessed at 12 months post SCI, compared to their predicted recovery expectations based on standard rehabilitation program
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Implantation of SCS lead in epidural space and implantation of neurostimulator in abdominal region
CHUV
Lausanne, Canton of Vaud, Switzerland
Safety Measure: occurence of Serious Adverse Event
Occurrence of Serious Adverse Event that are deemed related or possibly related to study procedure or to study investigational system
Time frame: Through study completion, until 12 months after injury
Feasibility Measure: use of TESS stimulation (in minutes) for improved mobility
Measure of the absolute and relative usage of TESS (in minutes) during mobility rehabilitation sessions.
Time frame: Through study completion, until 12 months after injury
Preliminary effectiveness: assessment of function recovery of leg motor function using the 6 mnWT distance
This endpoint will compare each patient's 6mnWT distance at 12 months post Date Of Injury to historical controls.
Time frame: Through study completion, until 12 months after injury
Preliminary effectiveness: mobility assessment using SCIM-III mobility score
This endpoint will compare each patient's SCIM-III mobility score at 12 months post Date Of Injury to historical controls.
Time frame: Through study completion, until 12 months after injury
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.